Why the study?
Intrapancreatic fat deposition correlates with increased risk and progression of acute pancreatitis, but the underlying molecular and cellular mechanisms remain poorly understood.
Design
Review
IPFD may prompt closer monitoring to mitigate SAP risk; leaves open precise mechanisms, generating hypotheses for mechanistic trials.
Acute pancreatitis (AP) is a common emergency of the digestive system, with some cases progressing to severe acute pancreatitis (SAP), which threatens life.Intrapancreatic fat deposition (IPFD) denotes the abnormal infiltration of lipid and pathological proliferation of adipocytes in pancreatic parenchyma.It has been demonstrated to bear a close correlation with the heightened risk and progressive development of acute pancreatitis, whereas the specific molecular and cellular mechanisms underlying this association remain poorly understood.This article elaborates on the mechanisms through which IPFD exacerbates acute pancreatitis from the following four perspectives: 1. IPFD causes pancreatic cell damage via lipotoxicity, such as inducing multiple forms of cell death in pancreatic acinar cells, damaging endothelial cells to trigger microcirculatory disorders, and interfering with ductal cells leading to pancreatic duct obstruction.2. IPFD prematurely activates pancreatic enzymes by inducing adipocyte dysfunction, thereby forming a vicious cycle.3. IPFD amplifies inflammatory responses by interfering with endocrine regulation.4. IPFD mediates pancreatic fibrotic dysfunction to amplify AP-associated injury.In addition, this article conducts a thorough review and raises the urgent key issues that remain to be addressed in current research on the association between IPFD and the development of AP, providing new insights for future clinical applications in the future.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: